HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 279, Issue 12, 11336-11343, March 19, 2004

This Article Full Text Full Text (PDF) All Versions of this Article: 279/12/11336    most recent M310258200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stedman, C. Articles by Liddle, C. Search for Related Content PubMed PubMed Citation Articles by Stedman, C. Articles by Liddle, C. Social Bookmarking                      What's this?

Feed-forward Regulation of Bile Acid Detoxification by CYP3A4

STUDIES IN HUMANIZED TRANSGENIC MICE^*

Catherine Stedman, Graham Robertson¶, Sally Coulter, and Christopher Liddle||**

From the Departments of Clinical Pharmacology and ^¶Medicine, University of Sydney, Molecular Pharmacology Laboratory and Storr Liver Unit, Westmead Millennium Institute and ^||Institute of Clinical Pathology and Medical Research, Westmead Hospital, New South Wales 2145, Australia

Bile acids are potentially toxic end products of cholesterol metabolism and their concentrations must be tightly regulated. Homeostasis is maintained by both feed-forward regulation and feedback regulation. We used humanized transgenic mice incorporating 13 kb of the 5' regulatory flanking sequence of CYP3A4 linked to a lacZ reporter gene to explore the in vivo relationship between bile acids and physiological adaptive CYP3A gene regulation in acute cholestasis after bile duct ligation (BDL). Male transgenic mice were subjected to BDL or sham surgery prior to sacrifice on days 3, 6, and 10, and others were injected with intraperitoneal lithocholic acid (LCA) or vehicle alone. BDL resulted in marked hepatic activation of the CYP3A4/lacZ transgene in pericentral hepatocytes, with an 80-fold increase in transgene activation by day 10. Individual bile acids were quantified by liquid chromatography/mass spectrometry. Serum 6-hydroxylated bile acids were increased following BDL, confirming the physiological relevance of endogenous Cyp3a induction to bile acid detoxification. Although concentrations of conjugated primary bile acids increased after BDL, there was no increase in LCA, a putative PXR ligand, indicating that this cannot be the only endogenous bile acid mediating this protective response. Moreover, in LCA-treated animals, 5-bromo-4-chloro-3-indolyl--D-galactopyranoside staining showed hepatic activation of the CYP3A4 transgene only on the liver capsular surface, and minimal parenchymal induction, despite significant liver injury. This study demonstrates that CYP3A up-regulation is a significant in vivo adaptive response to cholestasis. However, this up-regulation is not dependent on increases in circulating LCA and the role of other bile acids as regulatory molecules requires further exploration.

Received for publication, September 16, 2003 , and in revised form, December 17, 2003.

^* This work was supported in part by project grants from the National Health and Medical Research Council of Australia. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Recipient of financial support from the Clinical Hepatology Trust Fund Westmead Hospital, a Westmead Millennium Foundation Initiating Grant, New Zealand Gastroenterology Society/Ferring Pharmaceuticals Research Fellowship, and a National Health and Medical Research Council of Australia Postgraduate Medical Research Scholarship.

^** To whom correspondence should be addressed: Dept. of Clinical Pharmacology, Westmead Hospital, Darcy Rd., Westmead, New South Wales 2145, Australia. Tel.: 61-2-9845-6086; Fax: 61-2-9845-8351; E-mail: chris_liddle{at}wmi.usyd.edu.au.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Kumar, H. Qiu, N. Oezguen, H. Herlyn, J. R. Halpert, and L. Wojnowski Ligand Diversity of Human and Chimpanzee CYP3A4: Activation of Human CYP3A4 by Lithocholic Acid Results from Positive Selection Drug Metab. Dispos., June 1, 2009; 37(6): 1328 - 1333. [Abstract] [Full Text] [PDF]

				L. D. Beilke, L. M. Aleksunes, R. D. Holland, D. G. Besselsen, R. D. Beger, C. D. Klaassen, and N. J. Cherrington Constitutive Androstane Receptor-Mediated Changes in Bile Acid Composition Contributes to Hepatoprotection from Lithocholic Acid-Induced Liver Injury in Mice Drug Metab. Dispos., May 1, 2009; 37(5): 1035 - 1045. [Abstract] [Full Text] [PDF]

				S. Han and J. Y. L. Chiang Mechanism of Vitamin D Receptor Inhibition of Cholesterol 7{alpha}-Hydroxylase Gene Transcription in Human Hepatocytes Drug Metab. Dispos., March 1, 2009; 37(3): 469 - 478. [Abstract] [Full Text] [PDF]

				M. Hagio, M. Matsumoto, M. Fukushima, H. Hara, and S. Ishizuka Improved analysis of bile acids in tissues and intestinal contents of rats using LC/ESI-MS J. Lipid Res., January 1, 2009; 50(1): 173 - 180. [Abstract] [Full Text] [PDF]

				A. K. Deo and S. M. Bandiera Biotransformation of Lithocholic Acid by Rat Hepatic Microsomes: Metabolite Analysis by Liquid Chromatography/Mass Spectrometry Drug Metab. Dispos., February 1, 2008; 36(2): 442 - 451. [Abstract] [Full Text] [PDF]

				G. Kakiyama, H. Tamegai, T. Iida, K. Mitamura, S. Ikegawa, T. Goto, N. Mano, J. Goto, P. Holz, L. R. Hagey, et al. Isolation and chemical synthesis of a major, novel biliary bile acid in the common wombat (Vombatus ursinus): 15{alpha}-hydroxylithocholic acid J. Lipid Res., December 1, 2007; 48(12): 2682 - 2692. [Abstract] [Full Text] [PDF]

				K. A. Charles, L. P. Rivory, S. L. Brown, C. Liddle, S. J. Clarke, and G. R. Robertson Transcriptional Repression of Hepatic Cytochrome P450 3A4 Gene in the Presence of Cancer Clin. Cancer Res., December 15, 2006; 12(24): 7492 - 7497. [Abstract] [Full Text] [PDF]

				C. Stedman, C. Liddle, S. Coulter, J. Sonoda, J. G. Alvarez, R. M. Evans, and M. Downes Benefit of farnesoid X receptor inhibition in obstructive cholestasis PNAS, July 25, 2006; 103(30): 11323 - 11328. [Abstract] [Full Text] [PDF]

				G. Zollner, M. Wagner, T. Moustafa, P. Fickert, D. Silbert, J. Gumhold, A. Fuchsbichler, E. Halilbasic, H. Denk, H.-U. Marschall, et al. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-{alpha}/beta in the adaptive response to bile acids Am J Physiol Gastrointest Liver Physiol, May 1, 2006; 290(5): G923 - G932. [Abstract] [Full Text] [PDF]

				H.-U. Marschall, M. Wagner, K. Bodin, G. Zollner, P. Fickert, J. Gumhold, D. Silbert, A. Fuchsbichler, J. Sjovall, and M. Trauner Fxr-/- mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids J. Lipid Res., March 1, 2006; 47(3): 582 - 592. [Abstract] [Full Text] [PDF]

				D. Masson, L. Lagrost, A. Athias, P. Gambert, C. Brimer-Cline, L. Lan, J. D. Schuetz, E. G. Schuetz, and M. Assem Expression of the Pregnane X Receptor in Mice Antagonizes the Cholic Acid-Mediated Changes in Plasma Lipoprotein Profile Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2164 - 2169. [Abstract] [Full Text] [PDF]

				R. Davies, A. Schuurman, C. R. Barker, B. Clothier, T. Chernova, F. M. Higginson, D. J. Judah, D. Dinsdale, R. E. Edwards, P. Greaves, et al. Hepatic Gene Expression in Protoporphyic Fech Mice Is Associated with Cholestatic Injury but Not a Marked Depletion of the Heme Regulatory Pool Am. J. Pathol., April 1, 2005; 166(4): 1041 - 1053. [Abstract] [Full Text] [PDF]

				C. A. M. Stedman, C. Liddle, S. A. Coulter, J. Sonoda, J. G. A. Alvarez, D. D. Moore, R. M. Evans, and M. Downes Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury PNAS, February 8, 2005; 102(6): 2063 - 2068. [Abstract] [Full Text] [PDF]

				J. Sonoda, L. W. Chong, M. Downes, G. D. Barish, S. Coulter, C. Liddle, C.-H. Lee, and R. M. Evans Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites PNAS, February 8, 2005; 102(6): 2198 - 2203. [Abstract] [Full Text] [PDF]